Showing results (151-160 of 257) with videos related to
Sort By:
Pageof 26
The American Journal of Physiology|October 1, 1989
Bone response to normal weight bearing after a period of skeletal unloadingN D Sessions, B P Halloran, D D Bikle, et al.Bone|December 8, 2009
Calcitonin-gene-related peptide stimulates stromal cell osteogenic differentiation and inhibits RANKL induced NF-kappaB activation, osteoclastogenesis and bone resorptionLiping Wang, Xiaoyou Shi, Rong Zhao, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 20, 1999
Skeletal unloading causes resistance of osteoprogenitor cells to parathyroid hormone and to insulin-like growth factor-IP J Kostenuik, J Harris, B P Halloran, et al.Endocrinology|March 1, 1986
The role of 1,25-dihydroxyvitamin D in the inhibition of bone formation induced by skeletal unloadingB P Halloran, D D Bikle, T J Wronski, et al.The Journal of Surgical Research|September 22, 2009
Hyperkalemia following massive transfusion in traumaBrigham K Au, William D Dutton, Victor Zaydfudim, et al.Injury|October 6, 2009
Exsanguination protocol improves survival after major hepatic traumaVictor Zaydfudim, William D Dutton, Irene D Feurer, et al.Journal of Crohn'S & Colitis|June 21, 2014
Crohn's disease outpatients treated with adalimumab have an earlier secondary loss of response and requirement for dose escalation compared to infliximab: a real life cohort studyChristopher Ma, Vivian Huang, Darryl K Fedorak, et al.Journal of Clinical Gastroenterology|November 13, 2014
Outpatient Ulcerative Colitis Primary Anti-TNF Responders Receiving Adalimumab or Infliximab Maintenance Therapy Have Similar Rates of Secondary Loss of ResponseChristopher Ma, Vivian Huang, Darryl K Fedorak, et al.The Journal of Trauma|February 11, 2009
Early prediction of massive transfusion in trauma: simple as ABC (assessment of blood consumption)?Timothy C Nunez, Igor V Voskresensky, Lesly A Dossett, et al.British Journal of Cancer|November 3, 2017
Risk-adjusted colorectal cancer screening using the FIT and routine screening data: development of a risk prediction modelJennifer Anne Cooper, Nick Parsons, Chris Stinton, et al.Pageof 26